Is transient elastography a useful tool for screening liver disease?

Area of Science:

• Hepatology
• Diagnostic Imaging
• Non-invasive Liver Assessment

Background:

• Transient elastography (TE) is a novel, non-invasive method for quantifying liver stiffness, a key indicator of liver fibrosis.
• Studies demonstrate TE's good accuracy in predicting significant fibrosis and optimal accuracy for cirrhosis in chronic liver disease (CLD).
• Normal liver stiffness ranges from 3.3-7.8 KPa; a cutoff of 7.1 KPa effectively excludes significant fibrosis and cirrhosis with high negative predictive value.

Discussion:

• The positive predictive value for cirrhosis diagnosis improves significantly when high stiffness is confirmed by a second scan.
• Factors like fatty liver and metabolic syndrome can slightly elevate TE readings, potentially impacting test accuracy, with the cause (steatofibrosis vs. steatosis) remaining unclear.
• TE is valuable for screening liver clinic patients, differentiating HBV carriers, but is unreliable for predicting esophageal varices in cirrhotics.

Key Insights:

• TE offers a reliable, non-invasive alternative to liver biopsy for staging liver fibrosis.
• A high negative predictive value at 7.1 KPa allows for exclusion of significant fibrosis and cirrhosis.
• Confirmation of high stiffness values via repeat scans enhances the diagnostic accuracy for cirrhosis.

Outlook:

• Further research is needed to clarify the impact of steatosis on TE accuracy.
• Potential applications include screening high-risk populations like intravenous drug users and alcoholics.
• TE may play a crucial role in managing patients with chronic liver disease and viral hepatitis.